Telitacicept 
RemeGen
['lupus', 'telitacicept', 'emergent ']
#eular2023 #op0137 most impressive delta difference vs control in #lupus! in phase 3 rct in china, more patients in telitacicept, baff/april-i met sri-4 (delta 44% if data imputed; 34% without) vs placebo. no major safety. global phase 3 rct is in progress 
Rheumatologist. Interested in B-cells, Lupus, Sjogren, Pre-Connective Tissue Disease, Tennis, Running & Travelling 🌏